期刊文献+

强肝胶囊治疗慢性乙型肝炎肝纤维化的多中心临床研究 被引量:4

A multi-central clinical rrial of Qianggan capsule in treating patients with chronic hepatitis B liver fibrosis
下载PDF
导出
摘要 目的探讨强肝胶囊治疗乙型肝炎肝纤维化的疗效以及安全性。方法将乙型肝炎肝纤维化患者258例随机分为2组:2组均给予常规治疗,治疗组加用强肝胶囊,治疗6个月后观察临床治疗效果,肝功能、肝纤维化情况及不良反应发生情况。结果治疗组总有效率(92%)明显高于对照组(75%)。治疗后2组血清总胆红素(TBil)、血清丙氨酸氨基转移酶(ALT)、血清门冬氨酸氨基转移酶(AST)均较治疗前明显降低,白蛋白(ALB)不同程度升高;治疗组治疗后TBil、ALT、AST降低较对照组明显;2组患者治疗后肝纤维化血清学指标均下降,治疗组降低较对照组更为明显,特别是HA、PCⅢ和LN;治疗6个月后,2组TGF-β1、TIMP-1水平均较治疗前显著下降,MMP-1水平较治疗前显著升高,且治疗组TGF-β1、TIMP-1和MMP-1改善情况均优于对照组。治疗组不良反应轻微,不影响治疗。结论强肝胶囊不仅可改善患者临床症状及肝功能,而且具有明显改善肝脏纤维化程度的作用,是治疗乙型肝炎肝纤维化的有效药物之一。 Objective It is to explore the curative effect and safety of Qianggan capsule in treating for patients with chronic hepatitis B with hepatic fibrosis. Methods 258 patients with chronic hepatitis B with hepatic fibrosis were enrolled and ran- domly divided into control group and treatment group. Both of the groups were given normal therapy, and the treatment group was added with Qainggan capsule. After 6 months'treatment, the clinical curative effect, hepatic function, spectrum of liver fi- brosis and adverse reaction in both groups were observed. Results The total effective rate was 92% in treatment group, which was obviously higher than that of control group (75%). The levels of TBil, ALT, AST in both groups were decreased after treatment, and that of ALB was increased more or less; The decreasing levels of TBil, ALT, AST in the treatment group were more than those of control group. The serum markers of hepatic fibrosis in both groups dropped much, and the decreasing de- grees especially HA, PC ]]I and LN were more obviously in treatment group than that in control group. The levels of TGF - [3, , TIMP- 1 were significantly decreased and MMP- 1 was markedly increased in both groups after 6 months'treatment, and the improvements in treatment group were better. There was no obvious bad effect in both groups. Conclusion Qianggan capsule not only can improve the clinical symptoms and hepatic function, but also can obviously improve hepatic fibrosis, it is a satis- factory drug in the treatment for chronic hepatitis B with hepatic fibrosis.
出处 《现代中西医结合杂志》 CAS 2013年第13期1385-1388,共4页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 强肝胶囊 慢性乙型肝炎 肝纤维化 Qianggan capsule chronic hepatitis B hepatic fibrosis
  • 相关文献

参考文献9

二级参考文献41

共引文献94

同被引文献75

引证文献4

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部